Combined therapy, Cyclosporine A, Lupus nephritis, Urolithin A, Hyperinflammation, Pro-inflammatory pathways
CANCER, Gene Expression, Kinases, Resistance
Hepatocellular adenoma, male, obesity, molecular, atypical hepatocellular neoplasms, well-differentiated neoplasms of uncertain malignant potential.
PDAC, Transcriptomic analyses, gene expression, signaling pathways